4-[(4,4-Dimethyl-chroman-6-carbonyl)-methoxy-amino]-benzoic acid methyl ester

ID: ALA138844

PubChem CID: 11793457

Max Phase: Preclinical

Molecular Formula: C21H23NO5

Molecular Weight: 369.42

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COC(=O)c1ccc(N(OC)C(=O)c2ccc3c(c2)C(C)(C)CCO3)cc1

Standard InChI:  InChI=1S/C21H23NO5/c1-21(2)11-12-27-18-10-7-15(13-17(18)21)19(23)22(26-4)16-8-5-14(6-9-16)20(24)25-3/h5-10,13H,11-12H2,1-4H3

Standard InChI Key:  ANHGSIRAKDNVNC-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
    3.3917   -3.0417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9125   -3.3417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.8667   -3.3417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8375   -3.3500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3542   -3.0500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9792   -2.1375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.3167   -3.0375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8375   -3.9417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4292   -3.0417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4667   -2.4417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3875   -2.4417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.3167   -4.2500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.8750   -3.9417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5042   -2.4375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.3542   -4.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9500   -3.3417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4250   -2.4417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.9417   -2.1417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4667   -3.0417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9125   -3.9417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.9792   -1.5375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.8000   -3.9500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8000   -3.3500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8917   -2.6125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8292   -2.7375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3917   -4.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4542   -1.2417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  5  1  0
  5  3  2  0
  6 10  1  0
  7  4  1  0
  8 15  1  0
  9  2  1  0
 10 18  1  0
 11  1  2  0
 12  8  1  0
 13  3  1  0
 14  6  2  0
 15 13  2  0
 16  9  2  0
 17  9  1  0
 18 17  2  0
 19 16  1  0
 20  2  1  0
 21  6  1  0
 22 12  1  0
 23  7  1  0
 24  7  1  0
 25  7  1  0
 26 20  1  0
 27 21  1  0
  8  4  2  0
 10 19  2  0
 22 23  1  0
M  END

Associated Targets(Human)

SCC-38 (21 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

SCC-2 (20 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 369.42Molecular Weight (Monoisotopic): 369.1576AlogP: 3.74#Rotatable Bonds: 4
Polar Surface Area: 65.07Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 4.00CX LogD: 4.00
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.61Np Likeness Score: -0.17

References

1. Zacheis D, Dhar A, Lu S, Madler MM, Klucik J, Brown CW, Liu S, Clement F, Subramanian S, Weerasekare GM, Berlin KD, Gold MA, Houck JR, Fountain KR, Benbrook DM..  (1999)  Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors.,  42  (21): [PMID:10543887] [10.1021/jm990292i]

Source